Zonda, Incorporated is a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets. Its tests utilize proprietary technology that detects enzymes that are specific to the target microorganisms. The Zonda medical diagnostic tests are ideal for the clinical laboratory, point of care, and the over-the-counter (OTC) markets. Zonda's intellectual property position in enzymatic detection technology will give the company a unique position in the clinical diagnostic market where there is increasing need for simple, reliable, and cost-effective rapid point of care diagnostic tests. The company's first medical test, for Chlamydia, is currently sold throughout Europe under the HandiLab brand, and a U.S. launch is being planned. Zonda believes it will compete successfully with all current technologies, including the gold standard nucleic acid amplification testing (NAAT) technology, while offering several enhanced features.

For further information on Zonda, Inc., please visit: www.zondaincusa.com